Your Basket
Your Basket
There are no funds in your basket. To add funds to your basket use the Green Plus Icon wherever you see it next to a fund.
Fund name
Aberdeen American Growth  
Fidelity American  
Schroder UK Mid 250  
M&G Recovery  
Jupiter Merlin UK Growth  
Close Basket Open basket




It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table

If there is a yes vote in the upcoming Scottish referendum, will you look to move cash out of investments with exposure to Scotland?



You are here: Factsheet

Skandia Norway AXA Framlington Health

Underlying Fund

FE Crown Rating ( Underlying )

Fund Objective ( Underlying )

Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies.

Fund Manager ( Underlying )

Gemma Game




Primary Asset Class

Fund Size

NOK 18.52m as at 29-Aug-2014

Downloads ( Underlying )

Unit Name

Skandia Norway AXA Framlington Health





Initial Charge


Unit Currency




Annual Charge



NOK 32.58


NOK 32.58

Change (Offer)

-0.38 (-1.16%)

Unit LaunchDate


Performance Overview

Performance Charts

Cumulative Performance

  YTD 3m 6m 1y 3y 5y
Fund 18.77 13.19 13.78 34.15 107.18 128.20
Sector 3.51 2.39 3.21 5.87 21.52 30.46

Discrete Performance (%)

  2013 2012 2011 2010 2009
Fund 47.07 8.53 4.85 12.22 8.30
Sector 10.14 6.76 -5.30 8.11 18.93

Asset Allocation ( Underlying )

breakdown chart
  Asset Class % of Fund
US Equities 68.43
Swiss Equities 11.59
UK Equities 6.74
German Equities 2.81
Israeli Equities 2.11
Money Market 1.93
Irish Equities 1.54
Japanese Equities 1.26
French Equities 0.92
Canadian Equities 0.84
Australian Equities 0.79
South African Equities 0.72
Brazilian Equities 0.32

Regional Breakdown ( Underlying )

breakdown chart
  Region % of Fund
United States 68.43
Switzerland 11.59
United Kingdom 6.74
Germany 2.81
Israel 2.11
Cash 1.93
Ireland 1.54
Japan 1.26
France 0.92
Canada 0.84
Australia 0.79
South Africa 0.72
Brazil 0.32

Sector Breakdown ( Underlying )

breakdown chart
  Sector % of Fund
Specialty Pharma & Pharma 32.20
Healthcare Services & Enabling Technology / Tools 29.80
Devices 19.06
Biotech Product 17.01
Cash 1.93

All prices in Pence Sterling (GBX) unless otherwise specified. Price performance figures are calculated on a bid price to bid price basis with net income (dividends) reinvested. Performance figures are shown in Sterling.

Sign up for email alerts
Stay upto date on the latest fund research from FE
subscribe Readers of this page also looked at:
Readers of this Factsheet have not looked at any others
Add your comment
Reload Change mode
Enter the words above:
Send comment
Be the first to comment on this Factsheet.
  • Stay connected with FE trustnet
  • Authorised and Regulated by the
    Financial Conduct Authority
  • © Trustnet Limited . All Rights Reserved.
  • Please read our Terms of Use / Disclaimer
    and Privacy and Cookie Policy.
  • Data supplied in conjunction with Thomson Financial Limited,
    London Stock Exchange Plc,